Table 1.
Placebo | Isoflavone | ||
---|---|---|---|
Total | 8 | 11 | |
Age | Mean ± SD | 60.8 ± 7.7 | 55.9 ± 9.5 |
PSA | Mean ± SD | 7.4 ± 3.9 | 5.2 ± 2.3 |
cT | |||
T1c | 4 | 7 | |
T2a | 3 | 4 | |
T2b | 1 | ||
pT | |||
T2a | 1 | 1 | |
T2b | 3 | 9 | |
T2c | 1 | ||
T3a | 2 | ||
T3b | 2 | ||
Gleason | |||
3+3 | 2 | 1 | |
3+4 | 1 | 10 | |
4+3 | 1 | ||
4+5 | 4 | ||
R | |||
R0 | 6 | 10 | |
R1 | 2 | 1 |
PSA = Prostate-specific antigen
TNM classification: cT = clinical tumor category, pT = surgical-pathological tumor category, R = residual tumor